-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Bolt Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- Bolt Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$22.6M, a 13.9% decline year-over-year.
- Bolt Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$77.6M, a 4.89% increase year-over-year.
- Bolt Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$76.2M, a 15.6% increase from 2022.
- Bolt Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$90.3M, a 2.66% increase from 2021.
- Bolt Biotherapeutics, Inc. annual Operating Income (Loss) for 2021 was -$92.8M, a 88.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)